Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human APLP2 ELISA Kit (AC2440)
Cat.#: ASET-1029
Specifications
Description Human APLP2 ELISA Kit allows for the in vitro quantitative determination of human APLP2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2141 Mouse AKR7A2 ELISA Kit (AC3552) Quantitative inquiry ASET-1292 Human Glucose 6 Phosphate Isomerase ELISA Kit (AC2703) Quantitative inquiry ASET-1002 Human HDL ELISA Kit (AC2413) Quantitative inquiry ASET-1486 Mouse beta MSH ELISA Kit (AC2897) Quantitative inquiry ASET-2335 Human Ghrelin ELISA Kit (AC3746) Quantitative inquiry ASET-2394 Human VEGFB ELISA Kit (AC3805) Quantitative inquiry ASET-1786 Human NK-1R ELISA Kit (AC3197) Quantitative inquiry ASET-1656 Rat Neuritin ELISA Kit (AC3067) Quantitative inquiry ASET-2469 Mouse Npffr2 ELISA Kit (AC3880) Quantitative inquiry ASET-2536 Rat Somatostatin Receptor 2 ELISA Kit (AC3947) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket